Scinai Immunotherapeutics Reports Q3 2024 Results
Ticker: SCNI · Form: 6-K · Filed: Nov 25, 2024 · CIK: 1611747
| Field | Detail |
|---|---|
| Company | Scinai Immunotherapeutics Ltd. (SCNI) |
| Form Type | 6-K |
| Filed Date | Nov 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, business-update, foreign-private-issuer
TL;DR
Scinai Immunotherapeutics dropped its Q3 2024 earnings report and business update.
AI Summary
Scinai Immunotherapeutics Ltd. (formerly BiondVax Pharmaceuticals Ltd.) filed a Form 6-K on November 25, 2024, to report its Q3 2024 financial results and provide a business update, as announced in a press release on November 22, 2024. The company is incorporated in Israel and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with an update on Scinai Immunotherapeutics' financial performance and business progress during the third quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Scinai Immunotherapeutics Ltd. (company) — Filer
- BiondVax Pharmaceuticals Ltd. (company) — Former company name
- November 22, 2024 (date) — Date of press release
- Q3 2024 (period) — Financial reporting period
- November 25, 2024 (date) — Filing date
FAQ
What type of report is Scinai Immunotherapeutics filing?
Scinai Immunotherapeutics is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When did Scinai Immunotherapeutics announce its Q3 2024 financial results?
The company announced its Q3 2024 financial results and business update in a press release issued on November 22, 2024.
What is the former name of Scinai Immunotherapeutics Ltd.?
The former name of Scinai Immunotherapeutics Ltd. was BiondVax Pharmaceuticals Ltd.
What is the fiscal year end for Scinai Immunotherapeutics Ltd.?
The fiscal year end for Scinai Immunotherapeutics Ltd. is December 31.
What is the filing date of this Form 6-K?
This Form 6-K was filed on November 25, 2024.
Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-11-25 09:20:41
Filing Documents
- ea0222251-6k_scinai.htm (6-K) — 11KB
- ea022225101ex99-1_scinai.htm (EX-99.1) — 158KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001213900-24-101860.txt ( ) — 184KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Scinai Immunotherapeutics Ltd. Date: November 25, 2024 By: /s/ Amir Reichman Amir Reichman Chief Executive Officer 2